Ticker Details
BioLife Solutions, Inc. BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
IPO Date:	October 1, 2002
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 3.09%
Avg Daily Range (30 D):	$0.59 | 1.84%
Avg Daily Range (90 D):	$0.60 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	1.09M
Avg Daily Volume (90 D):	.77M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	1,768
Avg Institutional Trade:	$1.64M
Avg Institutional Trade (30 D):	$2.47M
Avg Institutional Trade (90 D):	$2.32M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.66M
Avg Closing Trade (30 D):	$2.87M
Avg Closing Trade (90 D):	$2.67M
Avg Closing Volume:	62.73K

News

Jul 30, 2026 @ 2:30 AM Halper Sadeh LLC is Investigating Whether UTZ, BLF... Source: Halper Sadeh Llc

Apr 23, 2026 @ 8:03 PM BioLife Solutions to Report First Quarter 2026 Fin... Source: Prnewswire

Apr 21, 2026 @ 8:15 PM BioLife Solutions Wins INTERPHEX 2026 Biotech Inno... Source: Prnewswire

Feb 26, 2026 @ 9:03 PM BioLife Solutions Reports Fourth Quarter and Full ... Source: Prnewswire

Feb 17, 2026 @ 1:04 PM BioLife Solutions to Report Fourth Quarter and Ful... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.92	$.02	$.24
Diluted EPS	$.91	$.02	$.23
Revenue	$28.47M	$27.5M	$18.79M
Gross Profit	$18.29M	$17.5M
Net Income / Loss	$45.1M	$1.19M	$11.07M
Operating Income / Loss	$1.7M	$.03M	$1.35M
Cost of Revenue	$10.18M	$10M
Net Cash Flow	$1.18M	$-10.22M	$3.56M
PE Ratio

Splits
Jan 29, 2014	1:14